The Lynx Group

Value-Based Cancer Care® publishes 10 times per year. The journal circulation is audited by BPA International, and mails to more than 17,000 providers, payers, purchasers, and policymakers.

Senior Vice President/Group Publisher
Nick Englezos
732.992.1884 This email address is being protected from spambots. You need JavaScript enabled to view it.

VP Business Development
Scott Hammersla
732.992.1890
This email address is being protected from spambots. You need JavaScript enabled to view it.

Read the Advertising Policy

Personalized Medicine | Browse By Specialty

We Want to Know

Is access to care an obstacle for patients today?


Latest Videos

Using FGFR Inhibitors in Clinical Practice Once FDA-Approved
Toxicities Associated with FGFR Inhibitors
Effective Targeted Therapies in CCA: IDH1 and FGFR

Subscribe to
Value-Based Cancer Care

Stay up to date with personalized medicine by subscribing to recieve the free VBCC print publication or weekly e‑Newsletter.

I'd like to recieve: